Age Cutoff for Early-Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease

被引:49
作者
Mehanna, Raja [1 ]
Smilowska, Katarzyna [2 ,3 ]
Fleisher, Jori [4 ]
Post, Bart [5 ]
Hatano, Taku [6 ]
Piemonte, Maria Elisa Pimentel [7 ]
Kumar, Kishore Raj [8 ,9 ,10 ]
McConvey, Victor [11 ]
Zhang, Baorong [12 ]
Tan, Eng-King [13 ]
Savica, Rodolfo [14 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, UTMove, Houston, TX 77030 USA
[2] Silesian Ctr Neurol, Dept Neurol, Katowice, Poland
[3] 5th Reg Hosp, Dept Neurol, Sosnowiec, Poland
[4] Rush Univ, Sch Med, Dept Neurol Sci, Chicago, IL 60612 USA
[5] Radboudumc, Dept Neurol, Nijmegen, Netherlands
[6] Juntendo Univ, Sch Med, Dept Neurol, Tokyo, Japan
[7] Univ Sao Paulo, Phys Therapy Speech Therapy & Occupat Therapy Dep, Med Sch, Sao Paulo, Brazil
[8] Univ Sydney, Fac Med & Hlth, Concord Repatriat Gen Hosp, Mol Med Lab, Sydney, NSW, Australia
[9] Univ Sydney, Fac Med & Hlth, Concord Repatriat Gen Hosp, Dept Neurol, Sydney, NSW, Australia
[10] Garvan Inst Med Res, Kinghorn Ctr Clin Genom, Darlinghurst, NSW, Australia
[11] Parkinsons Victoria, Elwood, Vic, Australia
[12] Second Affiliated Hosp, Dept Neurol, Hangzhou, Peoples R China
[13] Natl Neurosci Inst, Dept Neurol, Singapore, Singapore
[14] Mayo Clin, Dept Neurol, Rochester, MN USA
来源
MOVEMENT DISORDERS CLINICAL PRACTICE | 2022年 / 9卷 / 07期
关键词
Parkinson's disease; early onset; young onset; age cutoff; QUALITY-OF-LIFE; YOUNG-ONSET; REPRODUCTIVE FACTORS; CLINICAL-FEATURES; ESTROGEN USE; FAMILIAL AGGREGATION; GENDER-DIFFERENCES; CAUDATE-NUCLEUS; RISK; WOMEN;
D O I
10.1002/mdc3.13523
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Early-onset Parkinson's disease (EOPD)/young-onset Parkinson's disease (YOPD) is defined as Parkinson's disease (PD) with an age at onset (AAO) after age 21 years but before the usual AAO for PD. Consensus is lacking, and the reported maximal age for EOPD/YOPD has varied from 40 to 60 years, leading to a lack of uniformity in published studies and difficulty in harmonization of data. EOPD and YOPD have both been used in the literature, somewhat interchangeably. Objective To define the nomenclature and AAO cutoff for EOPD/YOPD. Methods An extensive review of the literature and task force meetings were conducted. Conclusions were reached by consensus. Results First, the literature has seen a shift from the use of YOPD toward EOPD. This seems motivated by an attempt to avoid age-related stigmatization of patients. Second, in defining EOPD, 56% of the countries use 50 or 51 years as the cutoff age. Third, the majority of international genetic studies in PD use an age cutoff of younger than 50 years to define EOPD. Fourth, many studies suggest that changes in the estrogen level can affect the predisposition to develop PD, making the average age at menopause of 50 years an important factor to consider when defining EOPD. Fifth, considering the differential impact of the AAO of PD on professional and social life, using 50 years as the upper cutoff for the definition of EOPD seems reasonable. Conclusions This task force recommends the use of EOPD rather than YOPD. It defines EOPD as PD with AAO after 21 years but before 50 years.
引用
收藏
页码:869 / 878
页数:10
相关论文
共 142 条
  • [1] Progression of motor impairment and disability in Parkinson disease - A population-based study
    Alves, G
    Wentzel-Larsen, T
    Aarsland, D
    Larsen, JP
    [J]. NEUROLOGY, 2005, 65 (09) : 1436 - 1441
  • [2] [Anonymous], MOV DISORD CLIN PRAC
  • [3] Study of familial Parkinson's disease in Russia, Uzbekistan, and Zambia
    Atadzhanov, M
    Zumla, A
    Mwaba, P
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2005, 81 (952) : 117 - 121
  • [4] The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson's disease
    Baraka, Azza M.
    Korish, Aida A.
    Soliman, Gehan A.
    Kamal, Hanan
    [J]. LIFE SCIENCES, 2011, 88 (19-20) : 879 - 885
  • [5] Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: An exploratory case-control study
    Benedetti, MD
    Maraganore, DM
    Bower, JH
    McDonnell, SK
    Peterson, BJ
    Ahlskog, JE
    Schaid, DJ
    Rocca, WA
    [J]. MOVEMENT DISORDERS, 2001, 16 (05) : 830 - 837
  • [6] Benetin, 2009, PARKINSONOVA CHOROBA
  • [7] Movement disorder society criteria for clinically established early Parkinson's disease
    Berg, Daniela
    Adler, Charles H.
    Bloem, Bastiaan R.
    Chan, Piu
    Gasser, Thomas
    Goetz, Christopher G.
    Halliday, Glenda
    Lang, Anthony E.
    Lewis, Simon
    Li, Yuan
    Liepelt-Scarfone, Inga
    Litvan, Irene
    Marek, Kenneth
    Maetzler, Corina
    Mi, Taomian
    Obeso, Jose
    Oertel, Wolfgang
    Olanow, C. Warren
    Poewe, Werner
    Rios-Romenets, Silvia
    Schaeffer, Eva
    Seppi, Klaus
    Heim, Beatrice
    Slow, Elizabeth
    Stern, Matthew
    Bledsoe, Ian O.
    Deuschl, Guenther
    Postuma, Ronald B.
    [J]. MOVEMENT DISORDERS, 2018, 33 (10) : 1643 - 1646
  • [8] Impact of disease stage and age at Parkinson's onset on patients' primary concerns: Insights for targeted management
    Bhidayasiri, Roongroj
    Boonmongkol, Thanatat
    Thongchuam, Yuwadee
    Phumphid, Saisamorn
    Kantachadvanich, Nitinan
    Panyakaew, Pattamon
    Jagota, Priya
    Plengsri, Rachaneewan
    Chokpatcharavate, Marisa
    Phokaewvarangkul, Onanong
    [J]. PLOS ONE, 2020, 15 (12):
  • [9] Genetic assessment of familial and early-onset Parkinson's disease in a Greek population
    Bozi, M.
    Papadimitriou, D.
    Antonellou, R.
    Moraitou, M.
    Maniati, M.
    Vassilatis, D. K.
    Papageorgiou, S. G.
    Leonardos, A.
    Tagaris, G.
    Malamis, G.
    Theofilopoulos, D.
    Kamakari, S.
    Stamboulis, E.
    Hadjigeorgiou, G. M.
    Athanassiadou, A.
    Michelakakis, H.
    Papadimitriou, A.
    Gasser, T.
    Stefanis, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (07) : 963 - 968
  • [10] Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2
    Bras, Jose
    Guerreiro, Rita
    Ribeiro, Maria
    Morgadinho, Ana
    Januario, Cristina
    Dias, Margarida
    Calado, Ana
    Semedo, Cristina
    Oliveira, Catarina
    Hardy, John
    Singleton, Andrew
    [J]. BMC NEUROLOGY, 2008, 8 (1)